Cytosurge Announces Strategic Leadership Transition

Cytosurge AG, a leader in single-cell manipulation, a biotech company pioneering innovative single-cell biopsies and cell-line engineering solutions, announces a leadership transition effective January 1, 2025.


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Pascal Behr, Ph.D., co-founder and CEO for 12 years, remains on the Board of Directors and continues to work closely as Delegate of the Board, ensuring continued strategic guidance. Simon Egli, previously Chief Commercial Officer, has been appointed CEO, a decision reflecting confidence in his leadership to advance the company’s next growth phase.

This leadership evolution strengthens Cytosurge’s commitment to integrating operational excellence and innovation, driving advancements in cell-line engineering and single-cell profiling to support both academic and commercial research.

“I want to thank Pascal on behalf of the Board of Directors for his exceptional leadership and dedication over the years, and Simon for stepping into this critical role,” said Martin Gertsch, Chairman of the Board. “Under Pascal’s guidance, Cytosurge achieved remarkable milestones: With over 140 FluidFM® systems installed globally, we have established ourselves at the forefront of single-cell research. FluidFM has been featured in more than 150 scientific publications, further solidifying its impact in advancing cutting-edge research. Additionally, the CellEDIT Service was launched under Pascal’s leadership, offering high-quality genetically engineered cell lines for research, setting a new standard in precision and innovation.”

Simon Egli is a seasoned business leader with over a decade of experience in the life sciences industry. Before joining Cytosurge, Simon held senior roles at INFORS HT, serving as Chief Commercial Officer and Global Sales Director, leading global sales operations and strategic initiatives. He also gained leadership experience as CEO of Infors USA, Inc., overseeing the company’s U.S. growth. Simon’s education was rooted in Switzerland, where he earned an International Executive MBA from the Rochester-Bern Executive Programs and a degree in Biotechnology from ZHAW Zurich University of Applied Sciences.

Reflecting on his tenure, Pascal Behr, Ph.D., said, “I am proud of what we’ve achieved together and I am confident that Simon, with his strategic vision and deep industry expertise, is well-positioned to lead Cytosurge to even greater heights.”

“I am honored to take on this role and look forward to advancing our mission of innovation in the cell-line engineering and single-cell profiling space”, added Simon Egli. “Together with our talented team, we are ready to push the boundaries of what’s possible in this field.”

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio